OUR MEDICAL SPECIALISTS  >  DEPARTMENT OF HEPATIC SURGERY & LIVER TRANSPLANTATION CENTER

Academician Xia Qiang, MD, PhD

Member, Chinese Academy of Engineering · President of Renji Hospital  |  Renji Hospital, SJTU School of Medicine

Academician Xia Qiang, MD, PhD
MEMBER, CHINESE ACADEMY OF ENGINEERING · PRESIDENT OF RENJI HOSPITAL

Academician Xia Qiang, MD, PhD

Department of Hepatic Surgery & Liver Transplantation Center
Renji Hospital, SJTU School of Medicine
  • Hospital Affiliation
    Renji Hospital, SJTU School of Medicine
  • Clinical Specialty
    Pediatric & Adult Liver Transplantation, Hepatocellular Carcinoma
  • Clinical Languages
    English, Mandarin
  • Clinical Experience
    32+ Years
  • Consultation Turnaround
    24–48 Hours Priority Review
Request Specialist Review →
ACCREDITED CHAIR PROFILE & CLINICAL OVERVIEW

World Leader in Pediatric & Adult Living-Donor Liver Transplantation

Academician Xia Qiang, MD, PhD, is a Member of the Chinese Academy of Engineering, President of Renji Hospital affiliated with Shanghai Jiao Tong University School of Medicine, and Director of the Shanghai Engineering Research Center of Organ Transplantation. He is universally acknowledged as a preeminent global authority on complex living-donor liver transplantation and liver cancer surgery.

Under Academician Xia's leadership, Renji Hospital has performed more than 3,500 pediatric living-donor liver transplants, ranking #1 in the world for 12 consecutive years. His surgical innovations in vascular reconstruction for infant portal vein thrombosis, small-for-size graft syndrome, and ABO-incompatible living-donor grafts have elevated long-term pediatric survival to an unprecedented 94.6%.

In oncologic surgery, Academician Xia specializes in complex anatomical liver resections for advanced hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC), and hepatoblastoma. His clinical team has developed groundbreaking downstaging and conversion protocols—combining TACE, targeted therapy, and PD-1 inhibitors—enabling previously inoperable liver cancer patients to undergo successful curative-intent salvage transplantation.

Primary Appointment President of Renji Hospital, Shanghai Jiao Tong University School of Medicine
Academic Distinction Member, Chinese Academy of Engineering (Elected 2021)
Center Leadership Director, Shanghai Liver Transplantation Center; President, International Pediatric Liver Transplantation Society
National Governance Chair, Pediatric Organ Transplantation Committee, Chinese Medical Association
CORE OPERATIVE MASTERY & CLINICAL EXCELLENCE

Procedural Frontiers & Department Innovations

Living-Donor Microvascular Reconstruction

Pioneered microvascular arterial and venous anastomosis techniques in neonates and infants weighing <5kg, with biliary complication rates <4%.

ABO-Incompatible Graft Protocols

Established advanced rituximab and plasma exchange desensitization regimens, achieving identical graft survival in blood type-mismatched donors.

HCC Downstaging & Liver Transplantation

Curative transplantation for liver tumors exceeding traditional Milan criteria following successful targeted-immunotherapy conversion.

Extreme Hepatobiliary Resections

Specializes in ex vivo liver resection and autotransplantation for massive tumors involving the inferior vena cava and hepatic confluence.

ACADEMIC AWARDS & LANDMARK TREATISES

Distinguished National & International Recognition

CAE MEMBER
Elected Member of Chinese Academy of Engineering
China's highest national lifetime honor for medical engineering and surgical science.
LANCET GASTROENTEROL
Pediatric Living-Donor Liver Transplantation Outcomes
Largest single-center cohort in medical history proving long-term quality of life and graft tolerance.
J HEPATOL
Downstaging Strategies for Advanced Hepatocellular Carcinoma
Definitive multi-modal trial expanding safe curative transplant windows in Asia.
NATIONAL AWARD
National Science & Technology Progress Award (2nd Class)
Conferred by the State Council for establishing China's standardized pediatric liver transplant program.

CASE INTAKE & LIVER TRANSPLANT TRIAGE

Request a Liver Surgical Case Review with Academician Xia Qiang, MD

Submit triple-phase dynamic liver MRI/CT DICOM imaging, hepatic function panels (Child-Pugh / MELD), AFP/PIVKA-II biomarkers, and past surgical/TACE history for direct review by Academician Xia Qiang and the Renji transplant board. Our team responds within 24–48 hours.

    Academician Xia Qiang, MD, PhD